Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000538914 | SCV000653540 | benign | Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type a, 11 | 2024-01-29 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001722513 | SCV000716122 | likely benign | not provided | 2018-12-05 | criteria provided, single submitter | clinical testing | |
Ce |
RCV001722513 | SCV005051460 | likely benign | not provided | 2024-06-01 | criteria provided, single submitter | clinical testing | B3GALNT2: BP4, BS2 |
Prevention |
RCV003945302 | SCV004763369 | likely benign | B3GALNT2-related disorder | 2023-05-05 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |